Simon Bernard Iloki Assanga

1.0k total citations
33 papers, 792 citations indexed

About

Simon Bernard Iloki Assanga is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Simon Bernard Iloki Assanga has authored 33 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Biochemistry and 4 papers in Pharmacology. Recurrent topics in Simon Bernard Iloki Assanga's work include Phytochemicals and Antioxidant Activities (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Retinal Diseases and Treatments (3 papers). Simon Bernard Iloki Assanga is often cited by papers focused on Phytochemicals and Antioxidant Activities (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Retinal Diseases and Treatments (3 papers). Simon Bernard Iloki Assanga collaborates with scholars based in Mexico, United States and France. Simon Bernard Iloki Assanga's co-authors include Lidianys María Lewis Luján, Mark F. McCarty, David Haines, James J. DiNicolantonio, Yolande Amet, James H. O’Keefe, Fadi Adas, F. Berthou, D. Picart and J.P. Salaün and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and Journal of Lipid Research.

In The Last Decade

Simon Bernard Iloki Assanga

33 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Bernard Iloki Assanga Mexico	14	281	190	141	138	91	33	792
Sung‐Joon Lee South Korea	18	369 1.3×	227 1.2×	155 1.1×	173 1.3×	59 0.6×	56	1.1k
Yeong‐Geun Lee South Korea	18	427 1.5×	190 1.0×	110 0.8×	114 0.8×	123 1.4×	79	855
Małgorzata Zakłos‐Szyda Poland	20	363 1.3×	243 1.3×	194 1.4×	211 1.5×	76 0.8×	44	909
Luis A. Salazar‐Olivo Mexico	16	370 1.3×	255 1.3×	117 0.8×	152 1.1×	140 1.5×	35	944
Emmanuel Mukwevho South Africa	15	462 1.6×	158 0.8×	90 0.6×	102 0.7×	129 1.4×	38	1.1k
Hang Fan China	17	527 1.9×	195 1.0×	176 1.2×	87 0.6×	74 0.8×	29	893
Ayodeji B. Oyenihi South Africa	15	161 0.6×	193 1.0×	118 0.8×	125 0.9×	76 0.8×	29	773
Jeong Hoon Pan South Korea	18	309 1.1×	114 0.6×	82 0.6×	82 0.6×	73 0.8×	49	749
Giuseppe Antonio Malfa Italy	20	407 1.4×	264 1.4×	263 1.9×	193 1.4×	54 0.6×	54	1.0k
Yuanyuan Zuo China	17	473 1.7×	212 1.1×	200 1.4×	81 0.6×	99 1.1×	41	1.2k

Countries citing papers authored by Simon Bernard Iloki Assanga

Since Specialization

Citations

This map shows the geographic impact of Simon Bernard Iloki Assanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Bernard Iloki Assanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Bernard Iloki Assanga more than expected).

Fields of papers citing papers by Simon Bernard Iloki Assanga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Bernard Iloki Assanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Bernard Iloki Assanga. The network helps show where Simon Bernard Iloki Assanga may publish in the future.

Co-authorship network of co-authors of Simon Bernard Iloki Assanga

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Bernard Iloki Assanga. A scholar is included among the top collaborators of Simon Bernard Iloki Assanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Bernard Iloki Assanga. Simon Bernard Iloki Assanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luján, Lidianys María Lewis, et al.. (2025). Fucoidan and fucoxanthin as therapeutic agents in age-related macular. Results in Chemistry. 17. 102547–102547. 1 indexed citations

Luján, Lidianys María Lewis, et al.. (2025). Role of Polyphenols in the Prevention and Treatment of Age‐Related Macular Degeneration. Molecular Nutrition & Food Research. 69(21). e70199–e70199. 1 indexed citations

Hernández, María, Lidianys María Lewis Luján, T. del Castillo-Castro, et al.. (2025). Role of Oxidative Stress and Inflammation in Age Related Macular Degeneration: Insights into the Retinal Pigment Epithelium (RPE). International Journal of Molecular Sciences. 26(8). 3463–3463. 10 indexed citations

Assanga, Simon Bernard Iloki, Lidianys María Lewis Luján, & Mark F. McCarty. (2023). Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options. European Journal of Pharmacology. 956. 175898–175898. 2 indexed citations

Luján, Lidianys María Lewis, Mark F. McCarty, J.C. Galvez-Ruiz, et al.. (2022). Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration. Nutrients. 14(9). 1985–1985. 40 indexed citations

Luján, Lidianys María Lewis, Johann Roider, Simon Bernard Iloki Assanga, et al.. (2022). Properties of Cephalopod Skin Ommochromes to Inhibit Free Radicals, and the Maillard Reaction and Retino-Protective Mechanisms in Cellular Models Concerning Oxidative Stress, Angiogenesis, and Inflammation. Antioxidants. 11(8). 1574–1574. 6 indexed citations

Luján, Lidianys María Lewis, et al.. (2022). Inhibition of Pathogenic Bacteria and Fungi by Natural Phenoxazinone from Octopus Ommochrome Pigments. Journal of Microbiology and Biotechnology. 32(8). 989–1002. 3 indexed citations

McCarty, Mark F., Lidianys María Lewis Luján, & Simon Bernard Iloki Assanga. (2022). Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass. International Journal of Molecular Sciences. 23(9). 4776–4776. 22 indexed citations

McCarty, Mark F., Simon Bernard Iloki Assanga, & Lidianys María Lewis Luján. (2021). Age-adjusted mortality from pancreatic cancer increased NINE-FOLD in japan from 1950 to 1995 – Was a low-protein quasi-vegan diet a key factor in their former low risk?. Medical Hypotheses. 149. 110518–110518. 1 indexed citations

10.

McCarty, Mark F., Simon Bernard Iloki Assanga, & Lidianys María Lewis Luján. (2020). Flavones and flavonols may have clinical potential as CK2 inhibitors in cancer therapy. Medical Hypotheses. 141. 109723–109723. 24 indexed citations

11.

Assanga, Simon Bernard Iloki, et al.. (2020). Comparative analysis of phenolic content and antioxidant power between parasitic Phoradendron californicum (toji) and their hosts from Sonoran Desert. Results in Chemistry. 2. 100079–100079. 7 indexed citations

12.

McCarty, Mark F., Simon Bernard Iloki Assanga, Lidianys María Lewis Luján, James H. O’Keefe, & James J. DiNicolantonio. (2020). Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond. Nutrients. 13(1). 47–47. 43 indexed citations

13.

McCarty, Mark F., et al.. (2019). Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia. Medical Hypotheses. 132. 109326–109326. 9 indexed citations

14.

McCarty, Mark F. & Simon Bernard Iloki Assanga. (2018). Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate Tolerance. Current Pharmaceutical Design. 24(20). 2250–2254. 3 indexed citations

15.

Assanga, Simon Bernard Iloki. (2013). Cell growth curves for different cell lines and their relationship with biological activities. 4(4). 60–70. 66 indexed citations

16.

Assanga, Simon Bernard Iloki, John F. Nomellini, P P Chiou, et al.. (2001). Recombinant vaccines against infectious hematopoietic necrosis virus: production by the Caulobacter crescentus S-layer protein secretion system and evaluation in laboratory trials. Diseases of Aquatic Organisms. 44(1). 17–27. 23 indexed citations

17.

Adas, Fadi, J.P. Salaün, F. Berthou, et al.. (1999). Requirement for ω and (ω–1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. Journal of Lipid Research. 40(11). 1990–1997. 56 indexed citations

18.

Adas, Fadi, D. Picart, F. Berthou, Simon Bernard Iloki Assanga, & Yolande Amet. (1998). Liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of ω- and (ω-1)-hydroxylated metabolites of elaidic and oleic acids in human and rat liver microsomes. Journal of Chromatography B Biomedical Sciences and Applications. 714(2). 133–144. 20 indexed citations

19.

Amet, Yolande, Simon Bernard Iloki Assanga, Elie Desmond‐Le Quéméner, et al.. (1992). Partial purification of 3α- and 3β-hydroxysteroid dehydrogenases from human hyperplastic prostate. Comparison between the two enzymes. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 689–692. 8 indexed citations

20.

Abalain, Jean-Hervé, Elie Desmond‐Le Quéméner, Jean‐Luc Carré, et al.. (1989). Metabolism of androgens in human hyperplastic prostate: Evidence for a differential localization of the enzymes involved in the metabolism. Journal of Steroid Biochemistry. 34(1-6). 467–471. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact